The development of a new therapy against interstitial lung disease using CNP
Project/Area Number |
26861135
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Respiratory surgery
|
Research Institution | National Cardiovascular Center Research Institute |
Principal Investigator |
Kimura Toru 国立研究開発法人国立循環器病研究センター, 研究所, 流動研究員 (90580796)
|
Project Period (FY) |
2014-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 肺外科 / 間質性肺炎 / 肺線維症 / 急性増悪 / ナトリウム利尿ペプチド |
Outline of Final Research Achievements |
We first developed a new mouse model of acute exacerbation (AE) of interstitial lung disease (ILD) for further investigation of prophylactic interventions. Secondly, our study revealed that C-type natriuretic peptide (CNP) had anti-inflammatory effect against LPS-induced acute lung injury mode (as one of the inflammatory stimulation models which induce AE) and anti-fibrotic effect against BLM-induced pulmonary fibrosis model. Additionally, our data suggest that CNP ameliorates bleomycin- induced pulmonary fibrosis by suppressing TGF-β signaling and myofibroblastic differentiation in lung fibroblasts. Therefore, we propose consideration of CNP for clinical application to treatment for pulmonary fibrosis and its exacerbation.
|
Report
(3 results)
Research Products
(16 results)
-
[Journal Article] C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.2016
Author(s)
Kimura T, Nojiri T, Hino J, Hosoda H, Miura K, Shintani Y, Inoue M, Zenitani M, Takabatake H, Miyazato M, Okumura M, Kangawa K.
-
Journal Title
Respiratory research
Volume: 17
Issue: 1
Pages: 19-19
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
[Journal Article] Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice2015
Author(s)
Kimura, T., Nojiri, T., Hosoda, H., Ishikane, S., Shintani, Y., Inoue, M., Miyazato, M., Okumura, M., Kangawa, K.
-
Journal Title
Cancer Chemotherapy and Pharmacology
Volume: 75(5)
Issue: 5
Pages: 1057-1063
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Presentation] C型ナトリウム利尿ペプチドによるヒト肺線維芽細胞の活性化抑制効果2015
Author(s)
木村亨, 野尻崇, 細田洋司, 三浦浩一, 新谷康, 川村知裕, 舟木壮一郎, 別所俊哉, 井上匡美, 南正人, 寒川賢治, 奥村明之進
Organizer
日本肺癌学会
Place of Presentation
横浜
Year and Date
2015-11-26
Related Report
-
-
-
[Presentation] 間質性肺炎急性増悪モデルマウスの作製と新規治療法の探索2015
Author(s)
木村亨, 野尻崇, 細田洋司, 日野純, 新谷康, 川村知裕, 舟木壮一郎, 別所俊哉, 井上匡美, 南正人, 寒川賢治, 奥村明之進
Organizer
関西胸部外科学会
Place of Presentation
岡山
Year and Date
2015-06-11
Related Report
-
-
-
[Presentation] 肺線維症に対するC型ナトリウム利尿ペプチドの効果2015
Author(s)
木村亨, 野尻崇, 細田洋司, 三浦浩一, 新谷康, 川村知裕, 舟木壮一郎, 井上匡美, 南正人, 寒川賢治, 奥村明之進
Organizer
日本呼吸器外科学会
Place of Presentation
香川
Year and Date
2015-05-14
Related Report
-
-
[Presentation] Bleomycin誘発肺障害マウスへのLipopolysaccharide吸入による間質性肺炎・肺線維症急性増悪モデルの作製2014
Author(s)
木村亨, 野尻崇, 細田洋司, 新谷康, 川村知裕, 舟木壮一郎, 中桐伴行, 井上匡美, 南正人, 寒川賢治, 奥村明之進
Organizer
第67回日本胸部外科学会定期学術集会
Place of Presentation
福岡
Year and Date
2014-09-30 – 2014-10-02
Related Report
-
-
-
[Presentation] Lipopolysaccaride誘発急性肺障害モデルマウスに対するC型ナトリウム利尿ペプチドの効果2014
Author(s)
木村亨, 野尻崇, 細田洋司, 新谷康, 川村知裕, 舟木壮一郎, 中桐伴行, 井上匡美, 澤端章好, 南正人, 寒川賢治, 奥村明之進
Organizer
第31回日本呼吸器外科学会総会
Place of Presentation
東京
Year and Date
2014-05-29 – 2014-05-30
Related Report